Increased rate of venous thrombosis may be associated with inpatient dihydroergotamine treatment

Neurology

Volumn 89, Issue 3, 2017, Pages 279-283

  Tso, Amy R ^a,b,c   Patniyot, Irene R ^a   Gelfand, Amy A ^a   Goadsby, Peter J ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIHYDROERGOTAMINE; LIDOCAINE; ANALGESIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CATHETER THROMBOSIS; CHILD; CLUSTER HEADACHE; CONTINUOUS INFUSION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DISEASE EXACERBATION; DRUG DOSE ESCALATION; DRUG DOSE TITRATION; FEMALE; HEADACHE; HEADACHE AND FACIAL PAIN; HOSPITAL ADMISSION; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MIDLINE CATHETER; MIGRAINE; NEW DAILY PERSISTENT HEADACHE; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SUNCT SYNDROME; VEIN THROMBOSIS; ADVERSE EFFECTS; COMPARATIVE STUDY; DEVICES; HOSPITAL PATIENT; INCIDENCE; INDWELLING CATHETER; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; STATISTICS AND NUMERICAL DATA; TERTIARY CARE CENTER; VENOUS THROMBOSIS; YOUNG ADULT;

ADMINISTRATION, INTRAVENOUS; ADOLESCENT; ADULT; AGED; ANALGESICS, NON-NARCOTIC; CATHETERS, INDWELLING; CHILD; DIHYDROERGOTAMINE; FEMALE; HUMANS; INCIDENCE; INPATIENTS; LIDOCAINE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RETROSPECTIVE STUDIES; TERTIARY CARE CENTERS; VENOUS THROMBOSIS; YOUNG ADULT;

EID: 85024474218     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0000000000004108     Document Type: Article

References (11)

1. Nagy AJ, Gandhi S, Bhola R, Goadsby PJ. Intravenous dihydroergotamine for inpatient management of refractory primary headaches. Neurology 2011;77: 1827-1832.
2. Chou DE, Tso AR, Goadsby PJ. Aprepitant for the management of nausea with inpatient IV dihydroergotamine. Neurology 2016;87:1613-1616.
3. Weatherall MW, Telzerow AJ, Cittadini E, Kaube H, Goadsby PJ. Intravenous aspirin (lysine acetylsalicylate) in the inpatient management of headache. Neurology 2010;75:1098-1103.
4. Chopra V, Ratz D, Kuhn L, Lopus T, Lee A, Krein S. Peripherally inserted central catheter-related deep vein thrombosis: contemporary patterns and predictors. J Thromb Haemost 2014;12:847-854.
5. Liem TK, Yanit KE, Moseley SE, et al. Peripherally inserted central catheter usage patterns and associated symptomatic upper extremity venous thrombosis. J Vasc Surg 2012;55:761-767.
6. Smitherman AB, Alexander T, Connelly M, et al. The incidence of catheter-associated venous thrombosis in noncritically ill children. Hosp Pediatr 2015;5:59-66.
7. Matharu MS, Cohen AS, Goadsby PJ. SUNCT syndrome responsive to intravenous lidocaine. Cephalalgia 2004;24: 985-992.
8. Aellig WH. Direct effects of vasoactive substances on superficial human veins in vivo. Int Angiol 1985;4: 235-242.
9. Labruijere S, Chan KY, de Vries R, et al. Dihydroergotamine and sumatriptan in isolated human coronary artery, middle meningeal artery and saphenous vein. Cephalalgia 2015;35:182-189.
10. MaassenVanDenBrink A, Reekers M, Bax WA, Ferrari MD, Saxena PR. Coronary side-effect potential of current and prospective antimigraine drugs. Circulation 1998;98: 25-30.
11. Iaquinto G, Ambrosone L, Rotiroti D, Cianciulli GM, Rambaldi M. A case of portal thrombosis arisen after treatment with dihydroergotamine. Ital J Gastroenterol 1991; 23:219-221.